Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aqualution Systems is a UK-based biotechnology company specializing in the development and manufacture of hypochlorous acid (HOCl) for infection control and biosecurity. The company utilizes a proprietary electrochemical process to produce stable, high-purity HOCl that is highly effective against a broad spectrum of pathogens, including bacteria, viruses, and spores. Their technology platform serves multiple sectors, including healthcare, food processing, agriculture, and veterinary medicine, providing a non-toxic alternative to traditional chemical disinfectants. Aqualution offers both packaged consumer products and industrial-scale on-site generation systems. The company's solutions are compliant with international biocidal regulations and are used globally for surface disinfection, water treatment, and wound care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aqualution Systems.